Mounjaro 10mg KwikPen

Mounjaro 10mg KwikPen contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management. It is taken once a week and helps with weight loss and blood sugar control.

Brand Name: Mounjaro

Composition: Tirzepatide

Mechanism of Action:

A dual GIP and GLP-1 receptor agonist, tirzepatide aids in controlling blood sugar levels in people with type 2 diabetes. It functions by slowing stomach emptying, which raises satiety and may aid in weight loss, decreasing glucagon levels to lower blood sugar, and increasing insulin production in response to meal consumption.

Uses:

·       Type-2 Diabetes Mellitus

·       Weight Management

Dosage and Administration:

·       The recommended dosage is 10 mg once weekly subcutaneously (abdomen, thigh, or upper arm, rotating sites).

·       After taking 7.5 mg once weekly for at least four weeks, this dosage is used.

·       The dosage can be raised by 2.5 mg every 4 weeks, up to a maximum of 15 mg once weekly, if further glycemic control is needed.

·       It can be taken with or without food, at any time of day; if a dose is missed, it should be taken within four days; otherwise, skip the dose and carry on as usual.

Side Effects:

·       Nausea

·       Vomiting

·       Diarrhea

·       Constipation

·       Decreased appetite

·       Injection site reactions (Itching, Rashes)

·       Hypoglycemia

Safety Advise:

Lungs  

The safety of Mounjaro for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Mounjaro for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Mounjaro for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Mounjaro should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Mounjaro while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Avoid freezing the Mounjaro KwikPen and keep it in a refrigerator between 2°C and 8°C. After usage, it can be stored for 21 days at room temperature (up to 30°C) under protection from heat and light.

How to use this Medication?

This drug is administered subcutaneously. You'll learn how to prepare and administer it. It is administered once every seven days, or once a week. Unless instructed otherwise by your healthcare provider, continue taking it.

You should inject this medication and insulin separately if you take both together. Don't combine them. Avoid administering the shots directly close to one another. With every injection, rotate the injection sites.

References:

1.   Baker DE, Walley K, Levien TL. Tirzepatide. Hospital Pharmacy. 2023 Jun;58(3):227-43.

2.  Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 Aug;65(8):1251-61.

3.  Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022 Jul 21;387(3):205-16.

4.  Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: a mini-review. Molecules. 2022 Jul 5;27(13):4315.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Eli Lilly and Company India Pvt Ltd

Address: Plot# 92, Sector 32, Institutional Area, Gurgaon-122001, HARYANA, INDIA

Country of origin: United states

Frequently Asked Questions:

1. What is Mounjaro 10mg KwikPen?
Mounjaro 10mg KwikPen contains Tirzepatide 10mg, an intermediate-to-high maintenance dose that may be considered for patients with Type 2 diabetes when lower doses have not achieved adequate blood sugar control.

2. When may the dose be escalated to 10mg?
A physician may consider increasing the dose to 10mg after at least 4 weeks on the 7.5mg dose, provided the patient is tolerating the current dose adequately and further glycaemic control is needed. This is a clinical decision made solely by your treating doctor.

3. What clinical benefits may the 10mg dose provide?
Some clinical trial data suggest that Tirzepatide 10mg may be associated with meaningful reductions in HbA1c and significant weight changes in certain patients. However, individual outcomes may vary considerably. Please consult your physician to understand realistic expectations for your specific situation.

4. How is the 10mg KwikPen used?
Inject subcutaneously once weekly at a clean, dry injection site. Rotation of injection sites (abdomen, thigh, or upper arm) is generally recommended each week. The pen is prefilled and ready to use as per the enclosed instructions.

5. What are the possible side effects of the 10mg dose?
Some patients may experience:
•         Nausea
•         Vomiting
•         Diarrhoea
•         Abdominal discomfort
•         Constipation
•         Fatigue
These may vary in frequency and intensity. Not all patients will experience them. Consult your doctor if side effects are persistent or distressing.

6. Should Mounjaro 10mg be taken with food?
Mounjaro may generally be administered with or without food, at any time of day. It is advisable to take it on the same day each week for consistency. Follow your doctor's specific instructions regarding administration.

7. What should I do if I accidentally take too much Mounjaro?
Contact your doctor or emergency services immediately if an accidental overdose occurs. An overdose may be associated with severe gastrointestinal symptoms or, if used alongside insulin, hypoglycaemia.

8. Can the Mounjaro 10mg pen be reused?
No. The KwikPen is intended for single-use only and should be disposed of appropriately after each injection. Pens must never be shared between patients.

9. Can Mounjaro 10mg be used in elderly patients?
Tirzepatide may be considered in elderly patients; however, age-related changes in kidney function and the risk of polypharmacy interactions require careful consideration. Close monitoring and appropriate dose selection are important in this population. Consult your doctor for personalised guidance.

10. Is Mounjaro 10mg available without a prescription?
No. All Mounjaro products, including the 10mg KwikPen, are prescription-only medicines that require a valid doctor's prescription.

Medical Disclaimer:
Mounjaro 10mg KwikPen is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, alter the dosage, or discontinue use without consulting your doctor. The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your physician before starting, changing, or stopping any medication.